BioStock: PK study in focus during Emplicure’s third quarter

During Emplicure’s third quarter, the focus has been on the pharmacokinetic study with the company’s main project Empli03, which is aimed at patients with chronic pain. A new CEO was also appointed during the quarter and a holding company structure was implemented. BioStock talked to the company’s newly appointed CEO Håkan Engqvist about the past quarter.

Read the full article about Emplicure at biostock.se 

https://www.biostock.se/en/2022/11/pk-study-in-focus-during-emplicures-third-quarter

This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se/en